- Miyamoto T, Sasaoka R, Kawaguchi M, Ishioka S, Inoue T, Yamada N, et al. Scedosporium apiospermum skin infection: a case report and review of the literature. J Am Acad Dermatol 1998; 39: 498–500.
- Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA. Pathology of Hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 1998; 29: 1266–72.
- Dupont B, Improvisi L, Ronin O. Aspects épidémiologiques et cliniques des infections à Scedosporium et à Pseudallescheria. J Mycol Med 1991; 118: 33–42.
- Jabado N,Casanova JL,Haddad E,Dulieu F,Fournet JC,Dupont B, et al. Invasive Pulmonary Infection Due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998; 27: 1437–41.
- Mylonakis E, Barlam TF, Flanigan T, Rich JD. Pulmonary aspergillosis and invasive disease in AIDS. Chest 1998; 114: 251–63.
- Eckburg PB, Zolopa AR, Montoya JG. Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. Clin Infect Dis 1999; 29: 212–3.
- Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149–51.
- Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42: 741–5.
Scandinavian Journal of Infectious Diseases
Volume 32, 2000 - Issue 4